Epzicom (Abamun L) is a trusted prescription medication that combines abacavir and lamivudine, two antiretroviral drugs widely used in the treatment of HIV-1 infection. It works by reducing the viral load in the body, helping the immune system recover, and lowering the risk of HIV-related complications. For more detailed clinical insights, you can refer to resources like Mayo Clinic, Drugs.com, and the U.S. FDA.
Key Benefits & Uses
-
Helps control HIV-1 infection by reducing viral replication.
-
Improves immune function by increasing CD4 cell count.
-
Lowers the risk of opportunistic infections and AIDS-related illnesses.
-
Convenient fixed-dose combination therapy for daily use.
-
Backed by extensive research from PubMed and recommendations from the World Health Organization.
How to Use
-
Take one tablet by mouth once daily, with or without food, as directed by your healthcare provider.
-
Adherence is essential—take it at the same time every day.
-
Do not stop without consulting your doctor, as sudden discontinuation may worsen your condition.
For additional guidance, check resources such as WebMD and Healthline.
Important Safety Information
-
A genetic test (HLA-B*5701) may be required before starting, as abacavir can cause a severe hypersensitivity reaction.
-
Inform your doctor about any history of liver disease, hepatitis B or C infection, or alcohol use.
-
Do not share this medicine with others, even if they have the same symptoms.
-
Safe use requires regular monitoring as recommended by the FDA.
Common Side Effects
-
Headache, nausea, fatigue, or diarrhea
-
Trouble sleeping
-
Rare but serious: hypersensitivity reaction, liver toxicity, or lactic acidosis
If you experience unusual symptoms, consult your doctor immediately or check Drugs.com for detailed side effect listings.
Why Choose Epzicom (Abamun L)?
-
Clinically proven effectiveness supported by studies on PubMed.
-
Recommended in many HIV treatment guidelines worldwide, including the WHO.
-
Simplified once-daily regimen improves adherence.
-
Widely prescribed with a strong safety and efficacy profile backed by Mayo Clinic.

